These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 14416677)

  • 21. [Effect of levomycetin on the respiration, pyruvic dehydrogenase and lactic acid in dysenterial bacteria].
    MOLIUK ED
    Antibiotiki; 1961 Dec; 6():1117-20. PubMed ID: 14475188
    [No Abstract]   [Full Text] [Related]  

  • 22. [STUDY OF SHIGELLA DYSENTERIAE TOXINS. 3. COMPARISON OF SOMATIC POLYSACCHARIDE COMPLEXES OF S- AND R-FORMS OF SHIGELLA DYSENTERIAE IN VIVO AND IN VITRO].
    SOUREK J
    Cesk Epidemiol Mikrobiol Imunol; 1963 Sep; 12():268-75. PubMed ID: 14082889
    [No Abstract]   [Full Text] [Related]  

  • 23. [A TOXIC FACTOR IN BACTERIA FROM THE FAMILY ENTEROBACTERIACEAE. I. CONDITIONS FOR THE ISOLATION AND PRELIMINARY SEROLOGICAL AND ELECTROPHORETIC ANALYSIS OF A THERMOLABILE TOXIN].
    BRANDES S; RADOLA BJ
    Med Dosw Mikrobiol; 1964; 16():183-91. PubMed ID: 14198033
    [No Abstract]   [Full Text] [Related]  

  • 24. INDUCIBLE LYTIC SYSTEMS IN THE GENUS BACILLUS.
    ALTENBERN RA; STULL HB
    J Gen Microbiol; 1965 Apr; 39():53-62. PubMed ID: 14328413
    [No Abstract]   [Full Text] [Related]  

  • 25. [STUDIES ON THE CHEMICAL COMPOSITION AND ANTIBACTERIAL AND ANTITOXIC PROPERTIES OF ROYAL JELLY].
    EMANUILOV I; VELCHEVA P; NACHEV L; TOSHKOV A; SHIROVA L
    Izv Mikrobiol Inst (Sofiia); 1963; 15():89-95. PubMed ID: 14122624
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in protein blood fractions in animals under the influence of dysenterial toxin].
    ALIMOVA LA
    Med Zh Uzb; 1962 Feb; 2():25-9. PubMed ID: 13860462
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in activities of some oxidation-reduction enzymes in Flexner's dysenterial bacteria during the process of the adaptation to levomycetin].
    PLOTNIKOVA MN
    Antibiotiki; 1962 Feb; 7():154-5. PubMed ID: 14487234
    [No Abstract]   [Full Text] [Related]  

  • 28. The action of the thermolabile toxin of Shigella dysenteriae on cells cultivated in vitro.
    VICARI G; OLITZKI AL; OLITZKI Z
    Br J Exp Pathol; 1960 Apr; 41(2):179-89. PubMed ID: 13842077
    [No Abstract]   [Full Text] [Related]  

  • 29. [Role of the sympathetic and parasympathetic innervations of the intestine in the development of dysenterial intoxication in puppies].
    GINZBURG MB
    Pediatriia; 1959 Oct; 37():38-42. PubMed ID: 13850259
    [No Abstract]   [Full Text] [Related]  

  • 30. [Properties of endotoxins from bacilli belonging to the family Enterobacteriacease with special reference to the variability of conversion of Shigella from S to R form].
    POGONOWSKA-GOLDHAR J
    Postepy Hig Med Dosw; 1961; 15():243-65. PubMed ID: 13736551
    [No Abstract]   [Full Text] [Related]  

  • 31. Some pharmacological properties of procain.
    RASKOVA H; VANECEK J; SEDA M; JELINEK J
    Arch Int Pharmacodyn Ther; 1962 Nov; 140():319-26. PubMed ID: 13973188
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxins of Shigella dysenteriae].
    MIKULASZEK E
    Med Dosw Mikrobiol; 1950; 2(2):197-9. PubMed ID: 14815315
    [No Abstract]   [Full Text] [Related]  

  • 33. [Production of a highly active Grigor'ev-Shiga toxin and its investigation by means of an electrophoretic method].
    EL'CHINOVA EA
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Feb; 32():16-60. PubMed ID: 13726280
    [No Abstract]   [Full Text] [Related]  

  • 34. [STUDIES ON THE SYNTHESIS OF NUCLEIC ACIDS AND PROTEINS IN THE LOGARITHMIC PHASE OF SH. FLEXNERI STRAINS RESISTANT AND SENSITIVE TO LEVOMYCETIN IN RELATION TO THE PRESENCE OF LEVOMYCETIN IN THE CULTURE MEDIUM].
    EGOROVA MN; OLIUNINA GK; TERESHIN IM
    Antibiotiki; 1964 Aug; 9():727-32. PubMed ID: 14239563
    [No Abstract]   [Full Text] [Related]  

  • 35. [EFFECT OF LEVOMYCETIN ON THE SYNTHESIS OF NUCLEIC ACIDS AND PROTEINS BY DYSENTERY BACTERIA].
    EGOROVA MN; OLIUNINA GK; TERESHIN IM
    Antibiotiki; 1963 Dec; 8():1091-6. PubMed ID: 14172765
    [No Abstract]   [Full Text] [Related]  

  • 36. [Elimination of pyogenic substances from purified an concentrated antitoxic serums].
    SZEGLI G; TOMA E; STANICA E; STOIAN C; GARTNER M
    Arch Roum Pathol Exp Microbiol; 1962 Mar; 21():163-70. PubMed ID: 13979895
    [No Abstract]   [Full Text] [Related]  

  • 37. Antitoxic immunity as protection against staphylococcic infection. An experimental study in mice and rabbits.
    LITHANDER A
    Acta Pathol Microbiol Scand; 1961; 53():356-62. PubMed ID: 14465858
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental oral and nasal antitoxic immunity].
    BRAZIL V; VELLARD J
    An Paul Med Cir; 1950 Nov; 60(5):565-79. PubMed ID: 14799831
    [No Abstract]   [Full Text] [Related]  

  • 39. Immuno-electrophoresis of antitoxic sera using a wide range of antigen-antibody ratios.
    GALL D
    Immunology; 1960 Jul; 3(3):214-25. PubMed ID: 13826065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [CONTRIBUTION TO THE PROBLEM OF DETERMINATION OF THE DEGREE OF DESPECIATION OF PURIFIED ANTITOXIC SERUMS].
    SZEGLI G; TOMA E; GARTNER M
    Arch Roum Pathol Exp Microbiol; 1963 Sep; 23():791-6. PubMed ID: 14165862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.